The pursuit of extended life has taken a digital turn as health apps promise to help users optimise their well-being and potentially prolong their lifespan. With the rise of technology and a growing interest in preventive healthcare, a new generation of applications is emerging, offering users insights into their health that were previously available only through traditional medical channels.
A century ago, health enthusiasts explored questionable methods like animal gland transplants and radioactive tonics in hopes of reversing aging. Today, the landscape is vastly different. Instead of bizarre treatments involving animal parts or hazardous substances, modern solutions focus on data-driven health insights and are primarily delivered via smartphones. While some apps are based on solid scientific principles, others remain unproven.
The market for longevity-focused health solutions is rapidly expanding. Tech entrepreneurs and biohackers, including followers of renowned neuroscientist Andrew Huberman, are among the early adopters of these apps. The goal is clear: to enhance sleep quality, improve physical health, and ultimately extend lifespan.
In the United States, the app Superpower, co-founded by Australian expat Max Marchione, is leading the charge. Valued at over $300 million, Superpower boasts a waiting list of more than 150,000 users. Meanwhile, similar developments are taking place in Australia, where several startups are vying for a share of the lucrative market.
Everlab, touted as Australia’s leading personal longevity clinic, offers a comprehensive service that combines diagnostics, virtual consultations, and artificial intelligence to combat chronic diseases. Founded by Marc Hermann, the company has attracted tens of thousands of Australians to its waiting list. The annual fee for its longevity program is $2,999, which includes screenings for over 1,000 diseases and a personalised health roadmap. A more affordable option, priced at $1,199, provides basic blood tests and doctor consultations.
Hermann believes that advancements in healthcare technology and a heightened awareness of personal health prompted by the COVID-19 pandemic have led to increased interest in services like Everlab. He envisions a future where individuals will have AI-assisted healthcare in their pockets, creating tailored health solutions based on a comprehensive understanding of their medical history and genetic background.
To date, Everlab has processed over 1 million biomarkers, with approximately 25% of test results showing abnormalities. For 2.5% of its members, these findings have been life-altering, revealing serious health conditions such as blocked arteries and early-stage cancers. Hermann aims to cater to everyday Australians, particularly those aged 40 to 60, who are increasingly concerned about maintaining their health.
Investor Laura Sillam from Left Lane Capital highlights a significant shift in consumer behaviour. “From concierge clinics to diagnostics memberships and longevity programs, consumers are increasingly willing to invest out-of-pocket in proactive health solutions,” she states. This trend is not limited to early adopters but reaches a broader audience seeking personalised healthcare experiences.
Everlab is among several local startups striving to establish themselves in this competitive landscape. Sydney-based firm Bright is developing a health “super app” aimed at attracting one million users by the end of 2026. Priced at just $20 per month, Bright seeks to democratise access to health data, making insights available to a wider audience. Chief Executive Officer Bryan Jordan asserts that everyone deserves a comprehensive view of their health, not just the tech-savvy.
In contrast, Superpower has gained attention as a leading player on a global scale. The app provides a yearly subscription for $499, which includes 24/7 concierge services and biannual lab testing that analyses over 100 blood biomarkers. Co-founder Max Marchione argues that the existing healthcare system often reacts to health issues rather than preventing them. Superpower aims to change this narrative.
Some individuals are taking extreme measures to achieve longevity. Bryan Johnson, a millionaire and subject of a recent Netflix documentary, has invested $4 million into his quest for immortality. His Blueprint project focuses on radical health practices, including blood plasma transfers and an intense daily regimen of supplements and medical treatments.
Closer to home, property developer Tim Gurner has garnered attention for his lavish biohacking initiatives. His Melbourne-based longevity club offers an annual package priced at $250,000, which includes comprehensive health testing and consultations.
While these innovations may seem extravagant, the question remains: can they benefit the average person? Professor Luigi Fontana from the University of Sydney, an expert in longevity, acknowledges the potential of apps like Everlab and Superpower. However, he cautions that the enthusiasm surrounding these platforms should not outpace scientific evidence. “These platforms have real potential to empower users with insights that complement – not replace – traditional healthcare,” he explains.
As the demand for personalised health solutions continues to grow, companies like Everlab are positioning themselves to meet the needs of everyday users. Hermann asserts that the goal is not to create an exclusive service for the wealthy but to provide accessible health insights to all Australians. The shift towards data-driven healthcare could redefine how individuals approach their well-being and longevity in the years to come.
